Clinical Trial Update: Synchronized Transcranial Magnetic Stimulation (sTMS) in Major Depressive Disorder [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating synchronized transcranial magnetic stimulation (sTMS) for major depressive disorder has completed, with results posted in July 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Synchronized Transcranial Magnetic Stimulation (sTMS) (sTMS)

Snippet

Sponsor: Wave Neuroscience | Conditions: Major Depressive Disorder | Phase 3 | Status: COMPLETED | Results posted: 2015-07-14